$120.76▲ 1.67 (1.40%)
Real-time prices · US MarketsHigh-quality business with 19% return on equity and 14% profit margins.
Quality
7.7
Health
7
Growth
6.2
Valuation
6.4
Sentiment
7.1
Analyst Target
$129.74
▲ +7.4% from current
Price Chart
Latest News
Fundamentals
Trailing P/E
34.0×
price-to-earnings
Forward P/E
12.6×
next 12 months est.
Market Cap
$298.3B
market capitalization
Div Yield
2.82%
dividend yield
Profit Margin
13.6%
net profit margin
Gross Margin
76.7%
revenue minus COGS
ROE
18.9%
return on equity
Beta
0.22
vs S&P 500
52-Week Range
$77 — $125
annual min — max
EPS — Estimate vs Actual
Frequently Asked Questions
What do analysts say about Merck & Company, Inc. right now?
Merck & Company, Inc.'s Q·Score is 6.9/10 (Neutral), reflecting its current fundamentals, analyst data, and valuation metrics. High-quality business with 19% return on equity and 14% profit margins. This is an informational data summary only and does not constitute financial advice. Always do your own research before making any investment decision.
What is the analyst price target for MRK?
The consensus price target for MRK is $129.74, based on ratings from 27 Wall Street analysts. This is 7.4% above the current price of $120.76. Price targets are forward-looking estimates and not guarantees of future performance.
Is MRK overvalued or undervalued?
Merck & Company, Inc. (MRK) scores in line with sector averages on valuation metrics. Its forward P/E ratio stands at 12.6×. The consensus analyst price target of $129.74 is 7% above the current price.
When does Merck & Company, Inc. report its next earnings?
Merck & Company, Inc.'s next earnings report is expected on approximately August 4, 2026.
What is Merck & Company, Inc.'s profit margin?
Merck & Company, Inc. has a net profit margin of 13.6%, which is solid for most industries. Its gross margin stands at 76.7%, indicating a high-margin business model.
What is MRK's dividend yield?
Merck & Company, Inc. currently offers a dividend yield of 2.82%, which is above the typical market average dividend yield. Dividend yields can change based on price movements and company payout decisions.
Is Merck & Company, Inc.'s revenue growing?
Merck & Company, Inc. is reporting modest revenue growth of 4.9%.
How much debt does Merck & Company, Inc. have?
Merck & Company, Inc. has a debt-to-equity ratio of 1.07×, reflecting a moderately high debt load — watch cash flow coverage. Its current ratio is 1.30×, suggesting it should be monitored for near-term liquidity.
Compare MRK with any stock